PROCEPT BioRobotics (PRCT) Preferred Stock Liabilities (2020 - 2021)
PROCEPT BioRobotics (PRCT) reported Preferred Stock Liabilities of $328.6 million for Q2 2021, up 34.74% quarter-over-quarter from $243.9 million in Q1 2021.
PROCEPT BioRobotics (PRCT) Preferred Stock Liabilities (2020 - 2021) Analysis & Trends
PROCEPT BioRobotics (PRCT) has 2 years of Preferred Stock Liabilities data on file, last reported at $328.6 million in Q2 2021.
- Preferred Stock Liabilities for Q2 2021 came in at $328.6 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2021 was $328.6 million (changed N/A YoY), and the FY2020 annual result was $243.9 million, changed N/A from the prior year.
- Preferred Stock Liabilities rose to $328.6 million in Q2 2021 per PRCT's latest filing, from $243.9 million in the prior quarter.
- Over five years, Preferred Stock Liabilities peaked at $328.6 million in Q2 2021 and troughed at $243.9 million in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | - |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | - |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | - |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | PROCEPT BioRobotics | 1.46 Bn | 1.21 Bn | 53.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 328.56 Mn |
| Mar 31, 2021 | 243.85 Mn |
| Dec 31, 2020 | 243.85 Mn |
| Sep 30, 2020 | 243.85 Mn |